Media Summary: Bethany Samuelson Bannow, an Assistant Professor of Medicine in Hematology at Oregon Health and Science University, joined ... Margaret Fang is a Professor of Medicine at the University of California San Francisco, a hospitalist physician, and serves as the ... Dr. Sam Goldhaber discusses the treatment of

Clot Chronicles Vte Risk In - Detailed Analysis & Overview

Bethany Samuelson Bannow, an Assistant Professor of Medicine in Hematology at Oregon Health and Science University, joined ... Margaret Fang is a Professor of Medicine at the University of California San Francisco, a hospitalist physician, and serves as the ... Dr. Sam Goldhaber discusses the treatment of Dr. Chris Holmes, an associate professor at the University of Vermont and Acting Director of the Division of Hematology and ... Dr. Gregory Piazza talks about the distinction—or lack thereof—between provoked and unprovoked Dr. Teresa Carman, the Director of Vascular Medicine at University Hospitals Cleveland Medical Center discusses the topic of ...

Dr. Alex Spyropoulos, Professor of Medicine at the Zucker School of Medicine at Hofstra/Northwell in New York, discusses the ... Dr. Sam Goldhaber discusses the prevention of Dr. Jean Connors, a hematologist at Brigham and Women's Hospital and Dana-Farber Cancer Institute discusses the Caravaggio ... Dr. Jean Connors, a hematologist at Brigham and Women's Hospital and Dana Farber Cancer Institute in Boston, Massachusetts ... Dr. Margaret Fang from the University of California, San Francisco, discusses 5 key questions to consider with periprocedural ... Dr. Gregory Piazza is one of the vascular medicine cardiologists at Brigham and Women's Hospital and the Education Chair on ...

Photo Gallery

Clot Chronicles: VTE Risk in the Hormonal Milieu
Clot Chronicles: Menstruation, Contraception, Anticoagulation, & VTE - What Providers Should Know
Clot Chronicles: VTE Risk and Gender-Affirming Therapy - A New NATF Action Initiative
Clot Chronicles: VTE in Ethnically Diverse Patients Hospitalized with COVID-19
Clot Chronicles: Challenging Situations in Patients with Cancer-Associated Thrombosis
Clot Chronicles: Treating Cancer-Associated VTE — Challenges, Caveats, and Controversies
Clot Chronicles: Cancer-Associated Thrombosis — Guideline Update
Clot Chronicles: Treating VTE In Cancer
Clot Chronicles: Antithrombotic Therapy in Patients with Afib or VTE Undergoing PCI
Clot Chronicles: Preventing VTE in Outpatients with Cancer
Clot Chronicles: Unprovoked vs Provoked VTE
Clot Chronicles: Travel-Related VTE
Sponsored
Sponsored
View Detailed Profile
Clot Chronicles: VTE Risk in the Hormonal Milieu

Clot Chronicles: VTE Risk in the Hormonal Milieu

On this episode of the

Clot Chronicles: Menstruation, Contraception, Anticoagulation, & VTE - What Providers Should Know

Clot Chronicles: Menstruation, Contraception, Anticoagulation, & VTE - What Providers Should Know

Bethany Samuelson Bannow, an Assistant Professor of Medicine in Hematology at Oregon Health and Science University, joined ...

Sponsored
Clot Chronicles: VTE Risk and Gender-Affirming Therapy - A New NATF Action Initiative

Clot Chronicles: VTE Risk and Gender-Affirming Therapy - A New NATF Action Initiative

In this episode of the

Clot Chronicles: VTE in Ethnically Diverse Patients Hospitalized with COVID-19

Clot Chronicles: VTE in Ethnically Diverse Patients Hospitalized with COVID-19

Margaret Fang is a Professor of Medicine at the University of California San Francisco, a hospitalist physician, and serves as the ...

Clot Chronicles: Challenging Situations in Patients with Cancer-Associated Thrombosis

Clot Chronicles: Challenging Situations in Patients with Cancer-Associated Thrombosis

In this episode of

Sponsored
Clot Chronicles: Treating Cancer-Associated VTE — Challenges, Caveats, and Controversies

Clot Chronicles: Treating Cancer-Associated VTE — Challenges, Caveats, and Controversies

In this episode of the

Clot Chronicles: Cancer-Associated Thrombosis — Guideline Update

Clot Chronicles: Cancer-Associated Thrombosis — Guideline Update

In this episode of the

Clot Chronicles: Treating VTE In Cancer

Clot Chronicles: Treating VTE In Cancer

Dr. Sam Goldhaber discusses the treatment of

Clot Chronicles: Antithrombotic Therapy in Patients with Afib or VTE Undergoing PCI

Clot Chronicles: Antithrombotic Therapy in Patients with Afib or VTE Undergoing PCI

On this episode of

Clot Chronicles: Preventing VTE in Outpatients with Cancer

Clot Chronicles: Preventing VTE in Outpatients with Cancer

Dr. Chris Holmes, an associate professor at the University of Vermont and Acting Director of the Division of Hematology and ...

Clot Chronicles: Unprovoked vs Provoked VTE

Clot Chronicles: Unprovoked vs Provoked VTE

Dr. Gregory Piazza talks about the distinction—or lack thereof—between provoked and unprovoked

Clot Chronicles: Travel-Related VTE

Clot Chronicles: Travel-Related VTE

Dr. Teresa Carman, the Director of Vascular Medicine at University Hospitals Cleveland Medical Center discusses the topic of ...

Clot Chronicles: Thrombotic Risk and Anticoagulation Benefits in Discharged COVID-19 Patients

Clot Chronicles: Thrombotic Risk and Anticoagulation Benefits in Discharged COVID-19 Patients

Dr. Alex Spyropoulos, Professor of Medicine at the Zucker School of Medicine at Hofstra/Northwell in New York, discusses the ...

NATF Clot Chronicles Preventing VTE in Cancer

NATF Clot Chronicles Preventing VTE in Cancer

Dr. Sam Goldhaber discusses the prevention of

Clot Chronicles: Revisiting the Caravaggio Trial - Key Findings for Patients with Cancer and VTE

Clot Chronicles: Revisiting the Caravaggio Trial - Key Findings for Patients with Cancer and VTE

Dr. Jean Connors, a hematologist at Brigham and Women's Hospital and Dana-Farber Cancer Institute discusses the Caravaggio ...

Clot Chronicles: DOAC Use in Challenging Patient Cases

Clot Chronicles: DOAC Use in Challenging Patient Cases

Stephanie Carlin, PharmD, a

Clot Chronicles: Approaching Your Patient with Cancer and Thrombosis

Clot Chronicles: Approaching Your Patient with Cancer and Thrombosis

Dr. Jean Connors, a hematologist at Brigham and Women's Hospital and Dana Farber Cancer Institute in Boston, Massachusetts ...

Clot Chronicles: Periprocedural Anticoagulation

Clot Chronicles: Periprocedural Anticoagulation

Dr. Margaret Fang from the University of California, San Francisco, discusses 5 key questions to consider with periprocedural ...

Clot Chronicles: PE-SARD—An Original Risk Score to Predict Bleeding in Acute PE

Clot Chronicles: PE-SARD—An Original Risk Score to Predict Bleeding in Acute PE

Dr. Gregory Piazza is one of the vascular medicine cardiologists at Brigham and Women's Hospital and the Education Chair on ...

Clot Chronicles: Menstruation, Contraception, Anticoagulation, & VTE: What clinicians should know.

Clot Chronicles: Menstruation, Contraception, Anticoagulation, & VTE: What clinicians should know.

In this vital episode of

Related Video Content

8 Signs of a Blood Clot - Cleveland Clinic Health Essentials information

Nov 18, 2025 · Blood clots can occur anywhere along the 60,000 miles of blood vessels in your body — and the symptoms...

CLOT - JUICESTORE information

CLOT is more than just clothes, it's a creative moment that celebrates individuality and injects life and character...

Blood Clots - How They Form and Common Causes - WebMD information

Nov 19, 2023 · A blood clot that forms in your vein is a thrombus, while an embolus is a blood clot that breaks away...

CLOT Definition & Meaning - Merriam-Webster information

2 days ago · The meaning of CLOT is a portion of a substance adhering together in a thick nondescript mass (as of...

12 Clots Pictures: Visual Guide to Blood Clotting and Key Warning Signs information

Oct 21, 2025 · Blood clots are clumps of blood that form when it thickens. This is a normal process to stop bleeding....